Zealand Pharma AS (ZLDPF)
116.06
-4.12
(-3.43%)
USD |
OTCM |
Nov 13, 16:00
Zealand Pharma Price to Book Value: 6.162 for Nov. 13, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 13, 2024 | 6.162 |
| November 12, 2024 | 6.381 |
| November 11, 2024 | 6.690 |
| November 08, 2024 | 6.463 |
| November 07, 2024 | 6.321 |
| November 06, 2024 | 6.654 |
| November 05, 2024 | 6.578 |
| November 04, 2024 | 6.557 |
| November 01, 2024 | 6.359 |
| October 31, 2024 | 6.106 |
| October 30, 2024 | 6.311 |
| October 29, 2024 | 6.311 |
| October 28, 2024 | 6.478 |
| October 25, 2024 | 6.478 |
| October 24, 2024 | 6.478 |
| October 23, 2024 | 6.349 |
| October 22, 2024 | 6.292 |
| October 21, 2024 | 6.191 |
| October 18, 2024 | 6.188 |
| October 17, 2024 | 6.071 |
| October 16, 2024 | 5.947 |
| October 15, 2024 | 6.072 |
| October 14, 2024 | 6.021 |
| October 11, 2024 | 6.072 |
| October 10, 2024 | 6.244 |
| Date | Value |
|---|---|
| October 09, 2024 | 6.106 |
| October 08, 2024 | 6.253 |
| October 07, 2024 | 6.110 |
| October 04, 2024 | 5.974 |
| October 03, 2024 | 6.140 |
| October 02, 2024 | 6.377 |
| October 01, 2024 | 6.531 |
| September 30, 2024 | 6.504 |
| September 27, 2024 | 6.443 |
| September 26, 2024 | 6.575 |
| September 25, 2024 | 6.943 |
| September 24, 2024 | 6.687 |
| September 23, 2024 | 6.694 |
| September 20, 2024 | 7.135 |
| September 19, 2024 | 7.017 |
| September 18, 2024 | 7.017 |
| September 17, 2024 | 7.086 |
| September 16, 2024 | 7.086 |
| September 13, 2024 | 7.193 |
| September 12, 2024 | 6.880 |
| September 11, 2024 | 6.941 |
| September 10, 2024 | 6.613 |
| September 09, 2024 | 6.574 |
| September 06, 2024 | 6.654 |
| September 05, 2024 | 6.525 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
4.389
Minimum
Feb 24 2022
30.51
Maximum
Dec 07 2022
10.67
Average
7.385
Median
Oct 19 2021
Price to Book Value Benchmarks
| Novo Nordisk AS | 26.32 |
| Genmab AS | 2.879 |
| Ascendis Pharma AS | -- |
| Galecto Inc | 0.4334 |
| Evaxion Biotech AS | 129.65 |
Price to Book Value Related Metrics
| PS Ratio | 660.57 |
| PEG Ratio | -2.927 |
| Price | 116.06 |
| Earnings Yield | -2.10% |
| Market Cap | 8.199B |
| PEGY Ratio | -2.927 |